Effects of Low-Intensity Blood Flow Restriction Training on Strength and Kicking Performance in Taekwondo Athletes
Summary
NIH registered a new clinical trial (NCT07538037) on ClinicalTrials.gov investigating the effects of low-intensity blood flow restriction training (LI-BFRT) on lower-limb strength and kicking performance in taekwondo athletes. The study examines physical performance and athletic performance conditions using LI-BFRT and HIRT interventions. This is an informational study registration; it creates no compliance obligations for external parties.
What changed
NIH registered a new clinical trial (NCT07538037) on ClinicalTrials.gov. The study investigates the effects of low-intensity blood flow restriction training on lower-limb strength and kicking performance in taekwondo athletes, with conditions listed as Physical Performance and Athletic Performance.
This study registration does not impose compliance obligations on any parties. It is an informational entry in the ClinicalTrials.gov registry and does not create regulatory requirements. Healthcare providers or clinical investigators conducting similar research should monitor ClinicalTrials.gov for updates if applicable.
Archived snapshot
Apr 20, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Effects of Low-Intensity Blood Flow Restriction Training on Strength and Kicking Performance in Taekwondo Athletes
N/A NCT07538037 Kind: NA Apr 20, 2026
Abstract
This study aims to investigate the effects of low-intensity blood flow restriction training (LI-BFRT) on lower-limb strength and kicking performance in taekwondo athletes. Blood flow restriction training is a method that partially restricts blood flow to the muscles during exercise, which may improve performance while reducing training load.
Conditions: Physical Performance, Athletic Performance
Interventions: LI-BFRT, HIRT
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.